Author:
Mwinga Kasonde,Vermund Sten H,Chen Ying Q,Mwatha Anthony,Read Jennifer S,Urassa Willy,Carpenetti Nicole,Valentine Megan,Goldenberg Robert L
Abstract
Abstract
Background
Reference values for hematological and biochemical assays in pregnant women and in newborn infants are based primarily on Caucasian populations. Normative data are limited for populations in sub-Saharan Africa, especially comparing women with and without HIV infection, and comparing infants with and without HIV infection or HIV exposure.
Methods
We determined HIV status and selected hematological and biochemical measurements in women at 20–24 weeks and at 36 weeks gestation, and in infants at birth and 4–6 weeks of age. All were recruited within a randomized clinical trial of antibiotics to prevent chorioamnionitis-associated mother-to-child transmission of HIV (HPTN024). We report nearly complete laboratory data on 2,292 HIV-infected and 367 HIV-uninfected pregnant African women who were representative of the public clinics from which the women were recruited. Nearly all the HIV-infected mothers received nevirapine prophylaxis at the time of labor, as did their infants after birth (always within 72 hours of birth, but typically within just a few hours at the four study sites in Malawi (2 sites), Tanzania, and Zambia.
Results
HIV-infected pregnant women had lower red blood cell counts, hemoglobin, hematocrit, and white blood cell counts than HIV-uninfected women. Platelet and monocyte counts were higher among HIV-infected women at both time points. At the 4–6-week visit, HIV-infected infants had lower hemoglobin, hematocrit and white blood cell counts than uninfected infants. Platelet counts were lower in HIV-infected infants than HIV-uninfected infants, both at birth and at 4–6 weeks of age. At 4–6 weeks, HIV-infected infants had higher alanine aminotransferase measures than uninfected infants.
Conclusion
Normative data in pregnant African women and their newborn infants are needed to guide the large-scale HIV care and treatment programs being scaled up throughout the continent. These laboratory measures will help interpret clinical data and assist in patient monitoring in a sub-Saharan Africa context.
Trial Registration
nicalTrials.gov Identifier NCT00021671.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference28 articles.
1. Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M: Approach to the patient with anemia: Hematology and Oncologyin the Merck Manual of Diagnosis and Therapy. 2006, Merck Research Laboratories, Division of Merck & Co., Inc. Whitehouse Station NJ, Chapter 3 (Section 11): 1031-1033. 18
2. Mukiibi JM, Mtimavalye LAR, Broadhead R, et al: Some hematological parameters in Malawian neonates. East Afr Med J. 1995, 72 (1): 10-14.
3. Miller MF, Stoltzfus RJ, Iliff PJ, et al: Effect of maternal and neonatal vitamin A supplementation and other postnatal factors on anemia in Zimbabwean infants: a prospective, randomized study. Am J Clin Nutr. 2006, 84 (1): 212-222.
4. Quintó L, Aponte JJ, Sacarlal J, et al: Hematological and biochemical indices in young African children: in search of reference intervals. Trop Med Int Health. 2006, 11 (11): 1741-1748. 10.1111/j.1365-3156.2006.01764.x.
5. Fleming AF, Harrison KA: Leukocyte counts during pregnancy and the puerperium and at birth in Nigerians. East Afr Med J. 1985, 62 (3): 175-184.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献